Proximity ligation assay (PLA) to identify HER2-negative breast carcinomas responding in HER-3 targeting agents. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results